Ramucirumab Intravenous and Sinemet 25-100
Determining the interaction of Ramucirumab Intravenous and Sinemet 25-100 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ramucirumab Intravenous-Sinemet 25-250
- Ramucirumab Intravenous-Sinemet 250/25
- Ramucirumab Intravenous-Sinemet CR
- Ramucirumab Intravenous-Sinemet CR 100/25
- Ramucirumab Intravenous-Sinemet CR 200/50
- Ramucirumab Intravenous-Sinequan
- Sinemet 25-100-Ranexa
- Sinemet 25-100-Ranibizumab
- Sinemet 25-100-Ranibizumab Intraocular
- Sinemet 25-100-Ranibizumab ophthalmic
- Sinemet 25-100-Ranitidine
- Sinemet 25-100-Ranitidine Capsule